Literature DB >> 16467115

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.

Steven E Come1, Aman U Buzdar, James N Ingle, Carlos L Arteaga, Myles Brown, Mitch Dowsett, Susan G Hilsenbeck, Rakesh Kumar, Stephen R D Johnston, Adrian V Lee, Soonmyung Paik, Kathleen I Pritchard, Eric P Winer, Carol Hart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16467115     DOI： 10.1158/1078-0432.CCR-05-2268

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

1.  Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.

Authors:  Adena E Rosenblatt; Maria Ines Garcia; Leah Lyons; Yingqiu Xie; Carol Maiorino; Laurent Désiré; Joyce Slingerland; Kerry L Burnstein
Journal:  Endocr Relat Cancer       Date:  2011-02-23       Impact factor: 5.678

2.  Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.

Authors:  Yamei Zhou; Christina Yau; Joe W Gray; Karen Chew; Shanaz H Dairkee; Dan H Moore; Urs Eppenberger; Serenella Eppenberger-Castori; Christopher C Benz
Journal:  BMC Cancer       Date:  2007-04-03       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.